OUP user menu

Instructions to Authors

1. Scope of the Journal
2. Preparation of manuscripts
  2.1 Article categories
  2.2 Authorship
  2.3 Manuscript Preparation
  2.4 Reference format
  2.5 Statistics
  2.6 Permissions information
  2.7 Supplementary data
  2.8 Sources of funding
3. Review of manuscripts
  3.1 Standard Review Process
  3.2 Fast Track Review Process
4. Other manuscript processing
  4.1 Manuscript transfer within the ESC Journal Family
5. Manuscript Acceptance
  5.1 Copyright Information
  5.2 Proofs
  5.3 Publication embargos
  5.4 Media Activity
  5.5 Open access option for authors
  5.6 Promoting readership and citations of research articles
  5.7 Self-archiving and post-print policy
  5.8 Online access and offprints

 

1. Scope of the Journal

The European Heart Journal (EHJ) is an international, peer-reviewed journal, engaged in publishing the highest quality material, both clinical and scientific, on all aspects of Cardiovascular Medicine. It is an official Journal of the European Society of Cardiology (ESC) and is published 48 times a year. It includes articles related to research findings, technical evaluations, and clinical reviews. It also provides a forum for the exchange of information on all aspects of Cardiovascular Medicine, including educational issues.

2. Preparation of manuscripts

2.1 Article categories

Manuscript Type General Information Parameters Figures Tables Misc
Clinical Paper studies based on either normal subjects or patients (case studies and reports not accepted) <5000 words

(incl references, figure legends and tables)
Only up to 30 references will be published; if more references are submitted, the reference list will be published online only.
Basic Science paper Reports on research performed either in experimental animals or cells, tissue or in vitro. <5000 words

(incl references, figure legends and tables)
Only up to 30 references will be published; if more references are submitted, the reference list will be published online only.
EHJ Brief Communication Observations – either at the clinical or experimental level – that are extremely interesting and intriguing, yet still in a preliminary observational phase <1500 words
max 15 references
one figure or table
All EHJ Brief Communication manuscripts are handled on a Fast Track basis.
Clinical Review Aim to summarize and critically evaluate research in the field addressed and identify future implications. <5000 words

(incl references, figure legends and tables)
Only up to 50 references will be published; if more references are submitted, the reference list will be published online only.
Editorials By invitation only <1500 words
max 15 references
one figure or table
_
Current opinion Provide focused coverage of topical issues in cardiovascular medicine and related disciplines which are of high current interest and potential <1500 words

(incl references, figure legends and tables)
max 15 references
_
Correspondence/E-letter Now transformed to online only e-letter platform. Must not contain any italics, bold type, or quotation marks. E-letters will be published within 14 days of submission in the system and will not receive PubMed entries.
Cardiovascular Flashlight Intended for striking, illustrative, or rare clinical images such as electrocardiograms, echocardiograms, tomographs, x-rays or pathology specimens. <250 words
Images should be submitted as one figure, (separate lettered panels if required), with an Aspect Ratio 1:1.
Max 4 authors
Inclusion of videos possible. Authors must submit still image for print article
Images in this category may be published on the cover of the Journal.

Further details:

Clinical papers: Clinical studies are based on either study subjects or patients. They should not exceed 5000 words in length (including tables, figure legends, and references). Only up to 30 references will be published in print; if this number is exceeded, the reference list will be published online only.

Basic Science papers: The results of cardiovascular basic science research will be considered for publication provided they have established clinical relevance. Basic science papers are defined as those which report on research performed either in experimental animals or cells, tissue or in vitro. Papers in this category should not exceed 5000 words in length (including tables, figure legends, and references). Only up to 30 references will be published in print; if this number is exceeded, the reference list will be published online only. A Translational Perspective (ca 100 words), which describes the value of the work in clinical operations, is also required for submissions of this category.

Clinical Reviews: EHJ publishes a limited number of scholarly, comprehensive clinical reviews, which critically evaluate research in the field and identify future implications. These Clinical Reviews should not exceed 5000 words in length (including tables, figure legends, and references). Only up to 30 references will be published in print; if this number is exceeded, the reference list will be published online only. Clinical reviews are invited by the Editorial Board, but unsolicited submissions will also be considered.

Editorials: All editorials are invited exclusively by the Editorial Board and should be limited to 1500 words (including tables, figure legends, and references), with a maximum of 15 references. Authors are highly encouraged to submit figures, illustrations, and/or sketches, which will then be rendered into illustrations by a medical graphics illustrator, as necessary.

Current Opinion: These papers provide the readership with focused coverage on highly topical issues in cardiovascular medicine and areas of related interest. Current opinions should be limited to 2500 words (including tables, figure legends, and references), with a maximum of 20 references.

EHJ Brief Communications: This manuscript category involves observations – either at the clinical or experimental level – that are extremely interesting and intriguing, yet still in a preliminary observational phase. Data of this nature may be key for stimulating research and, by extension, improved insights into mechanisms and/or clinical meaning. EHJ Brief Communications should not exceed 1500 words, and should be complemented by one illustration and up to 15 references. A short Abstract (ca 30 words) is required for administrative reasons. All EHJ Brief Communications submissions will be handled on a Fast Track review basis.

Cardiovascular Flashlights: These submissions involve striking and illustrative clinical images depicted by electrocardiograms, echocardiograms, tomography images, X-rays, or pathology specimens. These images may be published on the EHJ cover and should be submitted as one figure, with separate designated panels, as required. While the image may consist of individual panels, its outer perimeter should exhibit a 1:1 aspect ratio. The image should be submitted with the names of no more than four authors and the clinical message contained in the picture should be amplified in a 250-word description (no references), which will be included with the image. A short Abstract (ca 30 words) is required for administrative reasons. Please also include a short title with the submission. Authors are encouraged to include videos (formats: avi or mp4) with the submissions, which can be published in the article. Authors must also submit a still image which can be used in the print article. It is the editorial policy not to accept case studies/reports.

Interactive Cardiovascular Flashlights: This new feature is an abridged version of a Clinical Case with MCQs, available on the ESC website for case-based learning purposes. These interactive cases represent typically encountered clinical scenarios, discuss findings, work-up, and management in the light of applicable recommendations, guidelines, and key papers. Full versions of the Clinical Cases are submitted to the ESC Education department for review (for more information on the case format and upload process, contact education@escardio.org). Cases approved by the ESC are published on its website and submitted to the EHJ Editorial Board for validation. Upon validation by the EHJ Editorial Board, an abridged version of the case would be published in the EHJ (print and online) with a link to the full case - and related MCQs - posted on the ESC website. The Interactive Cardiovascular Flashlight has the same format and requirements as the Cardiovascular Flashlight.

E-letters: The former Letters to the Editor section has now been transformed into an E-letter platform. E-letters must not exceed 500 words and should focus on a specific article published in the EHJ. No original data may be included. For technical reasons, E-letters must not contain any italics, bold type, or quotation marks. The authors of the article cited will be invited to reply. The online publication of E-letters will be subject to assessment by the Editorial Board and they will not receive PubMed entries. Accepted E-letters and authors' responses will be published solely on the online E-letter platform, and will be published in print only in very exceptional cases. Publication of an E-letter does not imply approval, recommendation, or endorsement of its contents by the EHJ. To submit an E-Letter, go to the article's page, click 'Explore' and find the E-letter information below.

2.2 Authorship

All individuals listed as authors should qualify for authorship and should have participated sufficiently in the work to take public responsibility for appropriate portions of the content. Authors included in the manuscript should meet all of the following conditions: 1) substantial contributions to the conception and design, acquisition of data, or analysis and interpretation of data; 2) drafting the article or revising it critically for important intellectual content; and 3) final approval of the version to be published. Any other contributors to the work who do not qualify for authorship should be listed in an acknowledgement section. For further information about authorship, please refer to the ICMJE guidelines.

Conflict of interest: All authors must make a formal statement at the time of submission indicating any potential conflict of interest that might constitute an embarrassment to any of the authors if it were not to be declared and were to emerge after publication. Such conflicts might include, but are not limited to, shareholding in or receipt of a grant or consultancy fee from a company whose product features in the submitted manuscript or which manufactures a competing product.

EHJ follows the guidelines of the International Committee of Medical Journal Editors and an ICMJE disclosure of potential conflicts of interest (COI) form must be submitted for each author at the time of manuscript submission. Forms must be submitted even if there is no conflict of interest. It is the responsibility of the corresponding author to ensure that all authors adhere to this policy prior to submission.

A conflict of interest statement must also be included in the manuscript after any "Acknowledgements" and "Funding" sections and should summarize any conflicts of interest included on the ICMJE form. If there is no conflict of interest, authors must include 'Conflict of Interest: none declared'.

Author Responsibility Information: The corresponding author is responsible for completing the Author Responsibility Information which can be found in the “Additional Information” section of the submission process in the EHJ Editorial Manager online submission system. This information must be completed by the corresponding author and it stipulates the roles and responsibilities of each individual author who contributes to the submission. This information is required for submission.

Registration of clinical trials: All clinical trials, in particular those involving pharmaceuticals, devices, or aspects relating to nutrition, should be registered prospectively in publically accessible databases (www.clinicaltrials.gov and www.clinicaltrialsregister.eu), and the paper should include registration numbers and the name of the register. EHJ requires clinical trials to be reported according to CONSORT guidelines.

Animal experimentation: EHJ aims at detailed and high quality reporting of animal experiments and suggests authors follow the ARRIVE guidelines when preparing their manuscript. Authors may be required to provide evidence that they obtained ethical and /or legal approval prior to conducting the research.

Author Queries: Authors may send queries concerning the submission process, review process, and journal procedures to eurheartj@usz.ch. After the manuscript has been prepared in accordance with the Instructions to Authors, please go to the online submission system by clicking here. First-time users must click "Register" on the navigation menu at the top of the screen. The system will send an automatic e-mail with the user name and password. Detailed guidelines for authors and reviewers are available at the submission site.

2.3 Manuscript Preparation

Word Count: All submitted manuscripts must not exceed 5000 words (or for Current Opinions 1500 words, Editorials 1500 words and Correspondence 500 words), including tables, figure legends, and references. The number of tables and figures should be appropriate to the manuscript content and should not be excessive in number.

Style and spelling: Oxford English spelling should be used. Authors whose first language is not English are requested to have their manuscripts checked carefully before submission. This will greatly help expedite the review process.

Abbreviations:  Standard SI units of measurement should only be used.

Sections of the manuscript: Clinical and Basic Science papers should be divided into the following sections: (1) Title page, (2) Abstract and Keywords, (3) Translational Perspective (translational aspects; applicable only for Basic Science papers), (4) Introduction, (5) Methods, (6) Results, (7) Discussion, (8) Acknowledgements, (9) References, (10) Figure legends, (11) Appendices, (12) Text tables, (13) Figures, and (14) Supplementary files (if any).

General format: Prepare the manuscript text using a Word processing package (save in .doc format). Submission of PDF text files is not permitted. Manuscripts should be double-spaced, including text, tables, legends, and references. Each page should be consecutively numbered. Please avoid footnotes; use instead, and as sparingly as possible, parentheses within brackets. Enter text in the style and order of the journal. Type references in the correct order and style of the journal (see Reference Format below). Type unjustified, without hyphenation, except for compound words, and type headings in the style of the journal. Use the TAB key once for paragraph indents. Where possible, use Times New Roman for the text font and Symbol for the Greek and special characters. Use the word processing formatting features to indicate Bold, Italic, Greek, Maths, Superscript, and Subscript characters. Clearly identify unusual symbols and Greek letters. Differentiate between the letter “O” and zero, and the letter “I” and the number 1. Mark the approximate position of each figure and table. Check the final copy of your paper carefully since any spelling errors may be retained in a typeset version.

Title page: The title page should include the following: (1) the title, (2) the name(s) of authors, (3) the institution(s) where the work was performed, (4) the position, institution, and location of all authors, (5) the telephone number, fax number, and e-mail address of the corresponding author, (6) the institutional affiliations of the authors (including corporate appointments) should be acknowledged in a footnote.

Abstract: All abstracts must be restricted in length to 250 words and should also be submitted as a separate file (for administrative purposes only). The abstract should be formatted with the following headings: (1) Aims, (2) Methods and Results, (3) Conclusion, (4) Keywords. A maximum of six keywords may be submitted.

Translational Perspective (for Basic Science papers only): A short, clinical summary of ca 30 words to provide the reader with a very brief take-home message on relevant translational aspects for clinical applications. In the event of publication, this summary will appear below the abstract in both the online and print versions of the journal. It will also be included in the electronic Table of Contents sent to readers.

Tables: Tables should be typed with double spacing, but minimizing redundant space, and each table should be uploaded as a separate file. Wherever possible, tables should be submitted in portrait - as opposed to landscape - layout. Each table should be numbered in sequence using Arabic numerals. Tables should also have a title above and an explanatory footnote below.

Figures: Figures should be limited to the number necessary for clarity and must not duplicate data given in tables or in the text. Standard submissions should have no more than 8 total figures and tables. Any number exceeding this should be designated as supplementary online-only material. They must be suitable for high quality reproduction and should be submitted in the desired final printed size so that reduction can be avoided. Figures should be no larger than 125 (height) x 180 (width) mm (5 x 7 inches) and should be submitted under the respective header (“Figure”) and in files separates from that of the main manuscript.

Electronic submission of figures: Figures should be saved in TIFF format at a resolution of at least 300 pixels per inch at the final printed size for colour figures and photographs, and 1200 pixels per inch for black and white line drawings. While some formats can be converted into TIFFs by the publisher, conversion may alter the tones, resolution and contrast of the image. Digital colour art should be submitted in CMYK rather than RGB format, since the printing process requires colours to be separated into CMYK, and this conversion can alter the colour intensity and brightness. Please keep in mind that colours can appear differently on different screens and printers.

Photographs: Photographs should be of sufficiently high quality, i.e. JPG or TIFF formats with a minimum file size of 1 MB, and 300 dpi.  Please ensure that the photographs are of high quality with respect to detail, contrast, and low noise, to enable them to withstand loss of contrast and detail inherent in the printing process.

EHJ does not charge for colour figures

Line drawings: Please provide these as clear, sharp illustrations, suitable for reproduction as submitted. All labeling should be on the original. Faint and grey shading or stippling will be lost upon reproduction and should be avoided. If a figure has various shadings, please ensure that it is easy to differentiate between them, using standard shadings (see the hard copy of the journal for examples). There should be sufficient white space between lines and dots to ensure the areas will not fill in and look grey. If stippling is used, this should be made up of clear black dots with visible white space between them. Ensure that the size of the lettering is in proportion with the overall dimensions of the drawing. Ideally, the drawings should be submitted in the desired final printed size to avoid reduction. If submitting line drawings, which require reduction, please check that the lettering will be clearly legible after the drawing has been reduced to the size at which it will be printed. After reduction, letters should not be smaller than 2 mm in height.

Videos: Videos can now be published in the online article with a still image of the video appearing in the print version. Authors should submit videos in mp4 or avi format. Still images to be used in the article must be provided and should represent as best as possible the main subject of the video. Video files should be clearly named as video 1, video 2 etc, and still images should be named ‘video 1 still image’. Any supplementary videos not published in the article should be uploaded as supplementary data (see Supplementary Data).

Figure and video legends: These should be on a separate, numbered manuscript sheet grouped under the heading "Legends" on a separate sheet of the manuscript after the References. Define all symbols and abbreviations used in the figure. Common abbreviations and others in the preceding text should not be redefined in the legend.

Acknowledgements: Substantive contributions of individuals should be noted in an Acknowledgements section and entered before the Conflict of Interest (COI) statement.

Declaration of Helsinki: The authors should state that their study complies with the Declaration of Helsinki, that the locally appointed ethics committee has approved the research protocol and that informed consent has been obtained from the subjects (or their legally authorized representative).

2.4 Reference format

References should be identified in the text by Arabic numerals and numbered in the order cited. All references should be compiled at the end of the article in the Vancouver style (i.e. author-number system). Complete information should be given for each reference, including the title of the article, abbreviated journal title, and page numbers. All authors should be listed, i.e. “et al” should not be used.

Personal communications, manuscripts in preparation, and other unpublished data should not be cited in the reference list but may be mentioned in parentheses in the text. Authors should obtain permission from the source to cite unpublished data. Titles of journals should be abbreviated in accordance with Medline. If a journal is not listed in Medline, its name should be written out in full.

Article citation example:

1. Schroeder S, Baumbach A, Mahrholdt H. The impact of untreated coronary dissections on the acute and long-term outcome after intravascular ultrasound guided PTCA. Eur Heart J 2000;21:137-145.

Book citation example:

2. Nichols WW, Rourke MF. Aging, High Blood Pressure and Disease in Human. 3rd ed. London/Melbourne: Lea and Febiger; 1990.

Chapter citation example:

3. Nichols WW, O'Rourke MF. Aging, high blood pressure and disease in humans. In: Arnold E, ed. McDonald's Blood Flow in Arteries: Theoretical, Experimental and Clinical Principles. 3rd ed. London/Melbourne/Auckland: Lea and Febiger; 1990. p398-420.

Webpage citation example:

4. Panteghini M. Recommendations on use of biochemical markers in acute coronary syndrome: IFCC proposals. eJIFCC 14. http://www.ifcc.org/ejifcc/vol14no2/1402062003014n.htm (28 May 2004)

Where the date in parenthesis refers to the access date.

If using EndNote and/or Reference Manager to facilitate referencing citations (not required for submission), this journal's style is available for use.

2.5 Statistics

The application of adequate statistical methods is a prerequisite for publication in the EHJ (for a basic statement see ‘Uniform Requirements for Manuscripts Submitted to Biomedical Journals’, Ann Intern Med 1997 126: 36-47). The rationale of the EHJ regarding the statistical methods applied is ‘Be as simple as possible, but as sophisticated as needed’. For example, clinical trials with their formalized framework must meet more specific statistical standards than pathophysiological studies. Please find a summary of relevant points (and pitfalls) regarding study design, analysis and reporting here. For studies with a sophisticated design, the collaboration of a professional statistician is recommended.

2.6 Permissions information

If illustrations or figures are to be duplicated from previously published work, written permission must be obtained from both the publisher and the author, and a credit line indicating the source must be added in the relevant Figure Legend. If text material (250 to 300 words) is to be reproduced from published sources, written permission is required from both publisher and author. For shorter quotations, it is sufficient to add a bibliographic credit. Letters containing reprint permission for the reproduction of either text or illustrations must be included in the manuscript upload. Please indicate if it was not possible to obtain permissions.

If all illustrations and figures in the manuscript are original, have not been previously published and therefore do not require permission to reproduce, please include the following statement in the file uploaded for Permissions Information: “The authors do hereby declare that all illustrations and figures in the manuscript are entirely original and do not require reprint permission.”

2.7 Supplementary data

Supporting material that is not essential for inclusion in the main text of the manuscript, but would benefit the reader, can be made available as online-only content. The material should not be essential to understanding the conclusions of the paper, but should contain data that is additional or complementary and directly relevant to the article content. Such information might include more detailed methods, extended data sets/data analysis, list of investigators, or additional figures.

All supplementary data must be provided in suitable electronic formats (more information). All material to be considered as Supplementary data must be submitted at the same time as the main manuscript for peer review. It cannot be altered or replaced after the paper has been accepted for publication. Please ensure that the material intended as Supplementary data is clearly indicated as such upon submission and is referred to in the main manuscript, where necessary.

2.8 Sources of funding

Details of all funding sources for the work in question should be given in a separate section entitled 'Funding'. This should appear before the 'Acknowledgements' section.

The following rules should be followed:

a) The sentence should begin: ‘This work was supported by …’

b) The full official funding agency name should be given, i.e. ‘the National Cancer Institute at the National Institutes of Health’ or simply 'National Institutes of Health' not ‘NCI' (one of the 27 sub-institutions) or 'NCI at NIH’ (full RIN-approved list of UK funding agencies)

c) Grant numbers should be complete and accurate and provided in brackets as follows: ‘[grant number ABX CDXXXXXX]’

d) Multiple grant numbers should be separated by a comma as follows: ‘[grant numbers ABX CDXXXXXX, EFX GHXXXXXX]’

e) Agencies should be separated by a semi-colon (plus ‘and’ before the last funding agency)

f) Where individuals must be specified for certain sources of funding, the following text should be added after the relevant agency or grant number 'to [author initials]'.

An example is given here: ‘This work was supported by the National Institutes of Health [P50 CA098252 and CA118790 to R.B.S.R.] and the Alcohol & Education Research Council [HFY GR667789].

Oxford Journals will deposit all NIH-funded articles in PubMed Central. Authors must ensure that manuscripts are clearly indicated as NIH-funded using the guidelines above.

3. Review of manuscripts

3.1 Standard Review Process

All manuscripts submitted to the EHJ will be assessed by the Editorial Board. Some manuscripts will be returned to authors at this stage if they are deemed more appropriate for another journal, if the paper fails to meet submission requirements, or if they are deemed to have insufficient priority. Submissions that advance in the publication process will undergo appropriate peer review, and all papers provisionally accepted for publication will undergo a detailed statistical review.

3.2 Fast Track Review Process

To petition for fast track review status, corresponding authors must send their manuscript by e-mail to: fasttrack.eurheartj@usz.ch, ensuring that the manuscript adheres to the EHJ's Instructions to Authors. The accompanying cover letter should detail why the authors deem the manuscript suitable for fast track review. The Editorial Board will decide as to whether the manuscript is suitable for fast track or regular review. When petitioning for fast track review, corresponding authors should not enter their manuscripts simultaneously as regular submissions

The Editorial Office will communicate within 48 hours whether or not the fast track review process has been approved. Alternately, the submission may be considered in a standard review process. Please note that fast track review does not in any way guarantee acceptance of the manuscript.

The EHJ Editorial Office will notify the corresponding authors if their manuscript has been selected for Fast Track review. At this time they must then submit the manuscript in its entirety in the Editorial Manager system and notify the EHJ Editorial Office immediately after submission (eurheartj@usz.ch). The article type will then be converted into a Fast Track and reviewers will be invited.

For manuscripts entering fast track review, the initial Editorial decision will be made within 5 consecutive days. If provisionally accepted, a revised manuscript must be returned to the EHJ Editorial Office as stipulated in the relevant decision letter. If the manuscript is accepted for publication, it should be published online 10 days after acceptance and in print as soon as possible, provided galley proofs are returned to the publisher within 48 hours. The corresponding authors will receive a ‘Welcome to Oxford Journals’ email, which will notify them of the DOI of their paper and contain a link to the online license to publish, which must be completed before the paper can be published.

4. Other manuscript processing

4.1 Manuscript transfer within the ESC Journal Family

Oxford University Press (OUP) and the European Society of Cardiology (ESC) have introduced a means for transfer of manuscripts among the ESC family journals. Authors submitting to the EHJ will be given the opportunity to indicate whether or not their manuscript could be considered for transfer to a specialty journal if the EHJ is unable to consider their manuscript further.

If authors agree during the upload process to have their manuscript transferred, and the manuscript is henceforth approved for transfer, there will be no need for re-submission and any reviewer comments will be transferred, resulting in a reduced time to a decision. Click here for more information.

5. Manuscript Acceptance

5.1 Copyright Information

It is a condition of publication in the EHJ that authors grant an exclusive licence to the ESC. This ensures that requests from third parties to reproduce articles are handled efficiently and consistently and thus ensures that the article is disseminated as widely as possible. As part of the licence agreement, authors may use their own material in other publications, provided the EHJ is acknowledged as the original place of publication, and Oxford University Press (OUP) is notified in writing in advance. Upon receipt of accepted manuscripts at OUP, authors will be invited to complete an online licence to publish form.

Please note that by submitting an article for publication, OUP will retain the email address of the corresponding author for the purpose of further communication regarding the article. In the event of a change of personal information, OUP must be informed immediately. Upon acceptance for publication, OUP will contact the corresponding author directly. Please note that OUP does not retain copies of rejected articles.

5.2 Proofs

Page proofs will be submitted to the corresponding author electronically. These should be checked thoroughly for any changes or typographic errors.

It is the publisher’s intent to review and correct the proofs and publish the accepted work as soon as possible. To achieve this, it is mandatory that all corrections are returned to OUP within 3 days. Subsequent additional corrections will not be possible, hence please ensure that all amendments are marked up comprehensively in the proofs.

5.3 Publication embargos

If authors have embargos on papers, for example, if they are presenting their research results at a subsequent conference, publication can be delayed accordingly. Authors should include a note in the cover letter at submission, and also when returning proofs, about the embargo and the exact date and time the paper can be published.

5.4 Media Activity

In the event of manuscript acceptance, the authors may elect to issue a press release. In this case, please contact the publisher, OUP (wordmason@mac.com) or the ESC (press@escardio.org), copying the EHJ Editorial Office (eurheartj@usz.ch) in all correspondence.

5.5 Open access option for authors

EHJ authors have the option to publish their paper under the Oxford Open initiative, whereby, for a charge, their paper will be made freely available online immediately upon publication. After the manuscript is accepted, the corresponding author will be contacted and required to accept a mandatory licence-to-publish agreement using the OUP Author Services website. As part of the licensing process, you will be asked to indicate whether or not you wish to pay for open access. In the event the open access option is not selected, the paper will be published with standard subscription-based access and the authors will not be charged.

Oxford Open articles are published under Creative Commons licences. RCUK/Wellcome Trust funded authors publishing in EHJ can use the Creative Commons Attribution licence (CC-BY) for their articles. All other authors may use the Creative Commons Attribution Non-Commercial licence (CC-BY-NC).

Open Access charges can be paid using the OUP Author Services site. This enables the author to pay online with a credit/debit card, or request an invoice by email or post. The open access charges are as follows:

Regular charge:

  • CC BY: £2000/$3500/€3000
  • CC BY-NC: £1700/$3000/€2550

List B Developing country charge*:

  • CC BY: £1000/$1750/€1500
  • CC BY-NC: £850/$1500/€1275

List A Developing country charge*:

  • £0 /$0 / €0

*Visit our list of qualifying countries.

Orders from the UK will be subject to the current UK VAT charge. For orders from the rest of the European Union, OUP will assume that the service is provided for business purposes. Please provide a VAT number for yourself or your institution and ensure you account for your own local VAT correctly.

5.6 Promoting readership and citations of research articles

The European Society of Cardiology (ESC) is working with a new service known as Kudos to help our authors maximize the impact of their published work. Kudos provides a free set of tools to help you explain your work in new ways and share it both within your networks, and more widely. You can measure the results of these actions and track the resulting increase in downloads, readership and, ultimately, citations.
This service is free of charge and only takes a few minutes to set up. For more details, see www.growkudos.com.

5.7 Self-archiving and post-print policy

Authors may enter the post-print of their article in PubMedCentral, other subject repositories, or institutional repositories, but they must stipulate that public availability be delayed until 12 months after the first online publication. For further details on this policy, please visit:

Author Self-archiving Policy

5.8 Online access and offprints

Details of free online access will be sent to the corresponding author, who may then circulate them to co-authors. Offprints can be claimed using the Oxford Journals Author Services site, and the corresponding author will receive a link when the paper enters production. Late orders submitted after the journal is in press are subject to increased prices.